Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferences

View all Images (72)

Other Resources UpToDate PubMed

Mycetoma

Contributors: Wendemagegn Enbiale MD, MPH, PhD, Zachary Skabelund MD, Susan Burgin MD
Other Resources UpToDate PubMed

Synopsis

Mycetoma (also known as Madura foot) is a chronic, slowly progressive infection of the skin and subcutaneous tissue, typically resulting from traumatic inoculation of diverse groups of microorganisms. The causative agents are found in hot and humid climate regions in the soil, plants, woods, and decaying plant materials, and they belong to different genera of fungus (eumycetoma) or bacteria (actinomycetoma). Over 55 microorganisms are identified as causative agents, with Madurella mycetomatis, Acremonium, Fusarium, and Aspergillus species as the most common causative agents for eumycetoma, while Streptomyces somaliensis and Nocardia brasiliensis are the most common causative organisms for actinomycetoma. The geographic distribution of causative organisms varies, with eumycetoma most common in Africa and India, and actinomycetoma more prevalent in Latin America.

Mycetoma is primarily diagnosed in tropical, subtropical, and equatorial regions, predominantly affecting poor and marginalized populations with limited access to medical care. In 2017, the World Health Organization (WHO) categorized mycetoma as a Neglected Tropical Disease. Risk factors for mycetoma include trauma, skin exposure to soil and vegetation, male sex, and immunodeficiency. Studies have shown that more than 90% of cases occur in individuals older than 18 years. In about 85% of cases, mycetomas occur on the feet and lower extremities, where trauma and subsequent soil exposure are most likely. Mycetomas have been reported on other body areas less commonly (eg, hands, thighs, buttocks, forearms, shoulders, and head and neck).

After initial exposure to the pathologic organism, there is an incubation period of months to years. The time from initial manifestation to consultation is reported to range from 3 months to 50 years.

The clinical course is determined by the causative organism, the site of the lesion, and host factors. Actinomycetoma is more destructive, progresses rapidly, and invades bone earlier than eumycetoma. Most infections remain localized and may cause significant local destruction. Spread of infection can occur locally in a sporotrichoid distribution to the nearby lymphatic vessels and lymph nodes. Hematologic spread has also been demonstrated. Poorer prognosis may be associated with head and upper thigh lesions because they may extend intracranially and to visceral organs.

Related topic: actinomycosis

Codes

ICD10CM:
B47.9 – Mycetoma, unspecified

SNOMEDCT:
410039003 – Mycetoma

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

To perform a comparison, select diagnoses from the classic differential

Subscription Required

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Reviewed:03/18/2024
Last Updated:04/02/2024
Copyright © 2024 VisualDx®. All rights reserved.
Mycetoma
A medical illustration showing key findings of Mycetoma : Abscess, Chronic duration lasting years, Edema, Skin ulcer, History of trauma
Clinical image of Mycetoma - imageId=2698462. Click to open in gallery.  caption: 'A maroon plaque and an adjacent similar papule on the dorsal foot.'
A maroon plaque and an adjacent similar papule on the dorsal foot.
Copyright © 2024 VisualDx®. All rights reserved.